1. Home
  2. PWP vs AMPH Comparison

PWP vs AMPH Comparison

Compare PWP & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Perella Weinberg Partners

PWP

Perella Weinberg Partners

HOLD

Current Price

$17.57

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

Logo Amphastar Pharmaceuticals Inc.

AMPH

Amphastar Pharmaceuticals Inc.

HOLD

Current Price

$27.02

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PWP
AMPH
Founded
2006
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
PWP
AMPH
Price
$17.57
$27.02
Analyst Decision
Hold
Buy
Analyst Count
3
6
Target Price
$22.33
$31.00
AVG Volume (30 Days)
758.5K
380.6K
Earning Date
02-06-2026
11-06-2025
Dividend Yield
1.58%
N/A
EPS Growth
N/A
N/A
EPS
0.70
2.27
Revenue
$757,415,000.00
$723,305,000.00
Revenue This Year
N/A
$1.35
Revenue Next Year
$38.06
$5.10
P/E Ratio
$25.53
$11.81
Revenue Growth
N/A
N/A
52 Week Low
$14.12
$20.39
52 Week High
$27.03
$39.01

Technical Indicators

Market Signals
Indicator
PWP
AMPH
Relative Strength Index (RSI) 43.88 55.28
Support Level $17.10 $26.26
Resistance Level $17.86 $27.23
Average True Range (ATR) 0.55 0.76
MACD 0.01 0.06
Stochastic Oscillator 25.13 85.96

Price Performance

Historical Comparison
PWP
AMPH

About PWP Perella Weinberg Partners

Perella Weinberg Partners is an independent advisory firm that provides strategic and financial advice to a wide range of clients. The Company's activities as an investment banking advisory firm constitute a single business segment that provides a range of advisory services, including advice related to strategic and financial decisions, mergers and acquisitions execution, shareholder and defense advisory, financing and capital solutions advice with resources focused on restructuring and liability management, capital markets advisory, private capital placement, as well as specialized underwriting and research services for the energy and related industries.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient, or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment pharmaceutical products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: